237 related articles for article (PubMed ID: 25070240)
1. ISL-1 is overexpressed in non-Hodgkin lymphoma and promotes lymphoma cell proliferation by forming a p-STAT3/p-c-Jun/ISL-1 complex.
Zhang Q; Yang Z; Jia Z; Liu C; Guo C; Lu H; Chen P; Ma K; Wang W; Zhou C
Mol Cancer; 2014 Jul; 13():181. PubMed ID: 25070240
[TBL] [Abstract][Full Text] [Related]
2. A positive feedback regulation of ISL-1 in DLBCL but not in pancreatic β-cells.
Zhang Q; Yang Z; Wang W; Guo T; Jia Z; Ma K; Zhou C
Biochem Biophys Res Commun; 2014 Jul; 449(3):295-300. PubMed ID: 24845569
[TBL] [Abstract][Full Text] [Related]
3. Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.
Skinnider BF; Elia AJ; Gascoyne RD; Patterson B; Trumper L; Kapp U; Mak TW
Blood; 2002 Jan; 99(2):618-26. PubMed ID: 11781246
[TBL] [Abstract][Full Text] [Related]
4. Cucurbitacin-I (JSI-124) activates the JNK/c-Jun signaling pathway independent of apoptosis and cell cycle arrest in B leukemic cells.
Ishdorj G; Johnston JB; Gibson SB
BMC Cancer; 2011 Jun; 11():268. PubMed ID: 21702955
[TBL] [Abstract][Full Text] [Related]
5. Pdcd4 knockdown up-regulates MAP4K1 expression and activation of AP-1 dependent transcription through c-Myc.
Wang Q; Zhang Y; Yang HS
Biochim Biophys Acta; 2012 Oct; 1823(10):1807-14. PubMed ID: 22801218
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of Chushizi (Fructus Broussonetiae) on acetaminophen-induced rat hepatitis by inhibiting the Toll-like receptor 3/c-Jun N-terminal kinase/c-jun/c-fos/janus protein tyrosine kinase/activators of transcription 3 pathway.
Zhang Y; Biao Y; Chu X; Hao L; Shi C; Liu Y; Zhang Y; Wang X
J Tradit Chin Med; 2020 Dec; 40(6):965-973. PubMed ID: 33258348
[TBL] [Abstract][Full Text] [Related]
7. Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells.
Shackleford TJ; Zhang Q; Tian L; Vu TT; Korapati AL; Baumgartner AM; Le XF; Liao WS; Claret FX
Breast Cancer Res; 2011 Jun; 13(3):R65. PubMed ID: 21689417
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Fas expression by STAT3 and c-Jun is mediated by phosphatidylinositol 3-kinase-AKT signaling.
Ivanov VN; Krasilnikov M; Ronai Z
J Biol Chem; 2002 Feb; 277(7):4932-44. PubMed ID: 11733515
[TBL] [Abstract][Full Text] [Related]
9. JNK/c-Jun signaling pathway mediates the fluoride-induced down-regulation of MMP-20 in vitro.
Zhang Y; Li W; Chi HS; Chen J; Denbesten PK
Matrix Biol; 2007 Oct; 26(8):633-41. PubMed ID: 17611094
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 6 regulates the expression of programmed cell death ligand 1 in thyroid cancer.
Zhang GQ; Jiao Q; Shen CT; Song HJ; Zhang HZ; Qiu ZL; Luo QY
Cancer Sci; 2021 Mar; 112(3):997-1010. PubMed ID: 33247999
[TBL] [Abstract][Full Text] [Related]
11. Isoliquiritigenin inhibits the proliferation of human renal carcinoma Caki cells through the ROS-mediated regulation of the Jak2/STAT3 pathway.
Kim DH; Park JE; Chae IG; Park G; Lee S; Chun KS
Oncol Rep; 2017 Jul; 38(1):575-583. PubMed ID: 28560439
[TBL] [Abstract][Full Text] [Related]
12. c-myc but not Hif-1α-dependent downregulation of VEGF influences the proliferation and differentiation of HL-60 cells induced by ATRA.
Song G; Li Y; Zhang Z; Ren X; Li H; Zhang W; Wei R; Pan S; Shi L; Bi K; Jiang G
Oncol Rep; 2013 Jun; 29(6):2378-84. PubMed ID: 23588859
[TBL] [Abstract][Full Text] [Related]
13. c-JUN N-terminal kinase (JNK) is activated and contributes to tumor cell proliferation in classical Hodgkin lymphoma.
Leventaki V; Drakos E; Karanikou M; Psatha K; Lin P; Schlette E; Eliopoulos A; Vassilakopoulos TP; Papadaki H; Patsouris E; Medeiros LJ; Rassidakis GZ
Hum Pathol; 2014 Mar; 45(3):565-72. PubMed ID: 24457077
[TBL] [Abstract][Full Text] [Related]
14. ISL-1 promotes pancreatic islet cell proliferation by forming an ISL-1/Set7/9/PDX-1 complex.
Yang Z; Zhang Q; Lu Q; Jia Z; Chen P; Ma K; Wang W; Zhou C
Cell Cycle; 2015; 14(24):3820-9. PubMed ID: 26176407
[TBL] [Abstract][Full Text] [Related]
15. NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications.
Clementz AG; Rogowski A; Pandya K; Miele L; Osipo C
Breast Cancer Res; 2011 Jun; 13(3):R63. PubMed ID: 21679465
[TBL] [Abstract][Full Text] [Related]
16. Targeting the Janus-activated kinase-2-STAT3 signalling pathway in pancreatic cancer using the HSP90 inhibitor ganetespib.
Nagaraju GP; Mezina A; Shaib WL; Landry J; El-Rayes BF
Eur J Cancer; 2016 Jan; 52():109-19. PubMed ID: 26682870
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of EGR-1 by the interleukin-1-JNK-MKK7-c-Jun pathway.
Hoffmann E; Ashouri J; Wolter S; Doerrie A; Dittrich-Breiholz O; Schneider H; Wagner EF; Troppmair J; Mackman N; Kracht M
J Biol Chem; 2008 May; 283(18):12120-8. PubMed ID: 18281687
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase C epsilon regulation of translocator protein (18 kDa) Tspo gene expression is mediated through a MAPK pathway targeting STAT3 and c-Jun transcription factors.
Batarseh A; Li J; Papadopoulos V
Biochemistry; 2010 Jun; 49(23):4766-78. PubMed ID: 20469933
[TBL] [Abstract][Full Text] [Related]
19. The LIM/homeodomain protein Islet1 recruits Janus tyrosine kinases and signal transducer and activator of transcription 3 and stimulates their activities.
Hao A; Novotny-Diermayr V; Bian W; Lin B; Lim CP; Jing N; Cao X
Mol Biol Cell; 2005 Apr; 16(4):1569-83. PubMed ID: 15659653
[TBL] [Abstract][Full Text] [Related]
20. An abnormally high expression of ISL-1 represents a potential prognostic factor in gastric cancer.
Guo C; Wang W; Shi Q; Chen P; Zhou C
Hum Pathol; 2015 Sep; 46(9):1282-9. PubMed ID: 26142548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
